e.g. Tata motors, Reliance MF, 500570

Lincoln Pharmaceuticals Ltd. - Research Center

531633 LINCOLN Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 623.23 580.55 510.31 472.08 413.06
Expenses
Material consumed 292.64 280.02 243.09 219.78 201.33
Manufacturing expenses 11.66 11.47 10.25 8.33 6.84
Personnel expenses 112.45 102.90 93.16 70.47 56.47
Selling expenses 2.67 1.03 1.16 0.06 0.05
Adminstrative expenses 102.31 85.22 73.48 77.96 67.02
Expenses capitalised - - - - -
Cost of sales 521.74 480.64 421.14 376.61 331.71
Operating profit 101.49 99.91 89.17 95.47 81.35
Other recurring income 22.48 34.42 22.48 10.00 6.77
Adjusted PBDIT 123.97 134.33 111.65 105.47 88.12
Financial expenses 1.88 1.46 2.03 1.45 1.44
Depreciation 12.90 10.62 9.17 8.09 5.67
Other write offs - - - - -
Adjusted PBT 109.19 122.24 100.46 95.93 81.01
Tax charges 26.84 28.94 27.56 26.57 20.61
Adjusted PAT 82.35 93.30 72.90 69.36 60.41
Non recurring items - - -0.48 0.13 -
Other non cash adjustments - - - - -
Reported net profit 82.35 93.30 72.42 69.49 60.41
Earnigs before appropriation 589.81 510.97 420.69 341.31 272.33
Equity dividend 3.61 3.00 3.00 3.00 -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 586.20 507.96 417.68 338.31 272.33
Close
Add Lincoln Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Lincoln Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback